5//SEC Filing
Kelly Paul Edward 5
Accession 0001213900-23-007438
CIK 0001553643other
Filed
Feb 1, 7:00 PM ET
Accepted
Feb 2, 5:00 PM ET
Size
12.9 KB
Accession
0001213900-23-007438
Insider Transaction Report
Form 5
Kelly Paul Edward
DirectorChief Operating Officer
Transactions
- Gift
Stock Option (right to buy)
2021-07-08−18,000→ 132,000 totalExercise: $33.43Exp: 2031-01-07→ Common Stock (18,000 underlying) - Gift
Stock Option (right to buy)
2021-07-08−19,600→ 130,400 totalExercise: $8.80Exp: 2029-07-29→ Common Stock (19,600 underlying) - Gift
Stock Option (right to buy)
2021-07-08−6,400→ 41 totalExercise: $13.80Exp: 2025-11-12→ Common Stock (4,800 underlying) - Gift
Stock Option (right to buy)
2021-07-08−56,000→ 94,000 totalExercise: $43.47Exp: 2029-12-19→ Common Stock (56,000 underlying)
Footnotes (5)
- [F1]Represents a bona fide gift of stock options to family members and a family trust. An independent trustee is trustee of the trust.
- [F2]The options were granted on November 12, 2015. 25% of the options vested one year from the grant date and the remaining 75% of the options vested in equal quarterly increments of 6.25% of the initial option grant over the following three year period.
- [F3]The options were granted on July 29, 2019. 6.25% of the options vest each quarter from the date of grant.
- [F4]The options were granted on December 19, 2019. 6.25% of the options vest each quarter from the date of grant.
- [F5]The options were granted on January 7, 2021. 6.25% of the options vest each quarter from the date of grant.
Documents
Issuer
RELMADA THERAPEUTICS, INC.
CIK 0001553643
Entity typeother
Related Parties
1- filerCIK 0001658544
Filing Metadata
- Form type
- 5
- Filed
- Feb 1, 7:00 PM ET
- Accepted
- Feb 2, 5:00 PM ET
- Size
- 12.9 KB